NICE (UK) positive for Keytruda (pembrolizumab) with chemoradiotherapy for untreated locally advanced cervical cancer – Merck
NICE(UK): Pembrolizumab with chemoradiotherapy (external beam radiation therapy followed by brachytherapy) can be used, within its marketing authorisation, as an option for untreated International Federation of Gynecology and… read more.
